ROTHER HOUSE MEDICAL CENTRE — All Prescriptions & Medications — Page 10
Practice Code: M84021 | STRATFORD-UPON-AVON, CV37 6PP
Showing results 451-500 of 733
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 47 | 117 | £681 | +31.5% ▲ | |
| 47 | 266 | £502 | +298.6% ▲ | |
| Midazolam hydrochloride | 46 | 220 | £4.6K | +219.2% ▲ |
| Ciclosporin (Eye Anti Inflammatory) | 46 | 1,950 | £4.7K | +85.5% ▲ |
| 46 | 1,285 | £3.5K | +146.4% ▲ | |
| Betamethasone esters | 45 | 3,600 | £364 | -25.4% ▼ |
| Clindamycin phosphate | 45 | 2,160 | £427 | +173.6% ▲ |
| 45 | 2,500 | £388 | +41.7% ▲ | |
| 45 | 3,060 | £9.8K | +214.5% ▲ | |
| Bempedoic acid | 44 | 1,232 | £2.3K | +34.2% ▲ |
| Bicalutamide | 44 | 1,197 | £62 | +36.0% ▲ |
| Leuprorelin acetate | 44 | 44 | £8.8K | -5.1% ▼ |
| Phosphates (Rectal) | 43 | 126 | £3.1K | +251.8% ▲ |
| Erythromycin | 43 | 2,140 | £709 | +24.1% ▲ |
| Triptorelin embonate | 43 | 43 | £15.9K | +331.9% ▲ |
| Chlorhexidine gluconate | 43 | 18.3K | £376 | +45.6% ▲ |
| 43 | 5,050 | £583 | -10.8% ▼ | |
| Modafinil | 42 | 2,300 | £228 | +101.4% ▲ |
| Naratriptan hydrochloride | 42 | 360 | £68 | +60.6% ▲ |
| Galantamine | 42 | 1,176 | £1.4K | +11.0% ▲ |
| Betamethasone sodium phosphate | 42 | 3,027 | £406 | +241.6% ▲ |
| Indometacin | 42 | 2,702 | £173 | +166.9% ▲ |
| 42 | 2,749 | £703 | +42.9% ▲ | |
| Nitrazepam | 41 | 1,052 | £54 | -21.1% ▼ |
| Perampanel | 41 | 1,148 | £5.3K | +89.2% ▲ |
| Opicapone | 41 | 1,155 | £2.3K | +114.2% ▲ |
| Itraconazole | 41 | 1,453 | £687 | +205.6% ▲ |
| Raloxifene hydrochloride | 41 | 1,127 | £161 | +177.6% ▲ |
| Brimonidine tartrate | 41 | 390 | £190 | +2.7% ▲ |
| 41 | 3,960 | £295 | +102.7% ▲ | |
| Labetalol hydrochloride | 40 | 3,630 | £482 | +76.2% ▲ |
| Midodrine hydrochloride | 40 | 2,730 | £701 | -17.9% ▼ |
| Exenatide | 40 | 160 | £2.9K | +128.2% ▲ |
| Testosterone undecanoate | 40 | 40 | £3.2K | +57.5% ▲ |
| Febuxostat | 40 | 1,120 | £88 | +7.1% ▲ |
| Dexamethasone sodium metasulphobenzoate | 40 | 400 | £357 | +438.2% ▲ |
| 40 | 5,750 | £63 | +59.0% ▲ | |
| 40 | 1,665 | £4.2K | +0.3% vs avg | |
| Naftidrofuryl oxalate | 39 | 2,912 | £326 | +19.7% ▲ |
| Codeine phosphate | 39 | 10.8K | £246 | +171.7% ▲ |
| Domperidone | 39 | 4,089 | £627 | +9.3% ▲ |
| Erythromycin | 39 | 1,450 | £605 | +187.2% ▲ |
| Bempedoic acid/Ezetimibe | 38 | 1,064 | £2.0K | -37.8% ▼ |
| 38 | 1,530 | £2.7K | +155.9% ▲ | |
| Moxonidine | 37 | 1,400 | £179 | -33.5% ▼ |
| Tapentadol | 37 | 1,932 | £997 | -10.1% ▼ |
| Clindamycin hydrochloride | 37 | 2,296 | £191 | +269.6% ▲ |
| Leflunomide | 37 | 1,110 | £62 | -2.2% ▼ |
| Tacrolimus | 37 | 1,800 | £1.3K | -31.4% ▼ |
| 37 | 5,650 | £814 | +216.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.